back to Meetings page
  • IMMPACT-XXV
  • October 27-29, 2021

  • Co-chairs:
  • Robert Kerns, PhD (Yale University)
  • Christin Veasley, BSc (Chronic Pain Research Alliance)
  • Academia and Related Participants
  • Robert H. Dworkin, PhD (University of Rochester)
  • Dennis C. Turk, PhD (University of Washington)
  • Allan Basbaum, PhD (University of California San Francisco)
  • Stephen Bruehl, PhD (Vanderbilt University)
  • Christine Chambers, PhD (Dalhousie University)
  • Robert Edwards, PhD (Harvard Medical School)
  • James Eisenach, MD (Wake Forest School of Medicine)
  • Scott Evans, PhD (George Washington University)
  • John T. Farrar, MD, PhD (University of Pennsylvania)
  • McKenzie Ferguson, PharmD (Southern Illinois University)
  • Roy Freeman, MD (Harvard Medical School)
  • Jennifer S. Gewandter, PhD (University of Rochester)
  • Ian Gilron, MD (Queen's University)
  • Hanna Grol-Prokopczyk, PhD (University of Buffalo)
  • Simon Haroutounian, PhD (Washington University)
  • Jennifer Haythornthwaite, PhD (Johns Hopkins University)
  • Sharon Hertz, MD (Hertz and Fields Consulting)
  • Katherine Holzer, PhD (Washington University)
  • Jonathan Jackson, PhD (Harvard Medical School)
  • Mark Jensen, PhD (University of Washington)
  • Cornelia Kamp, MBA (University of Rochester)
  • Francis Keefe, PhD (Duke University)
  • Bethea (Annie) Kleykamp, PhD (University of Rochester)
  • Dale Langford, PhD (University of Rochester)
  • Sean Mackey, MD, PhD (Stanford University)
  • John D. Markman, MD (University of Rochester)
  • Kathryn Martin, PhD (University of Aberdeen)
  • Ewan McNicol, PharmD (Tufts University)
  • Karen Morales, BS (University of Maryland)
  • Kushang Patel, PhD (University of Washington)
  • Andrew S.C. Rice, MD (Imperial College London)
  • Michael Rowbotham, MD (University of California San Francisco)
  • Lee S. Simon, MD (SDG Consulting)
  • Lena Sun, MD (Columbia University)
  • Jan Vollert, PhD (Imperial College London)
  • Government Participants
  • David Atkins MD (Department of Veterans Affairs)
  • Rebecca Baker, PhD (National Institutes of Health)
  • Robyn Bent, RN, MS (Food and Drug Administration)
  • Nathalie Bere, MPH (European Medicines Agency)
  • Kristin Carman, PhD (Patient-Centered Outcomes Research Institute)
  • Alysha Croker, PhD (Health Canada)
  • Laure Forsyth, PhD (Patient-Centered Outcomes Research Institute)
  • Christine Goertz, DC, PhD (Patient-Centered Outcomes Research Institute)
  • Smriti Iyengar, PhD (National Institutes of Neurological Disorders and
  • Stroke)
  • Karim Khan, MD, PhD, MBA (Canadian Institutes of Health Research)
  • Rachel Knowles, MD, PhD (Medical Research Council)
  • Steven Lane (Patient-Centered Outcomes Research Institute)
  • Friedhelm Sandbrink, MD (Veterans Health Administration)
  • Jeremy Taylor, OBE (National Institute for Health Research)
  • Patient Representatives
  • Penney Cowan (American Chronic Pain Association)
  • Gail Graham (University of Maryland)
  • Isabel Jordan, BSc (Dalhousie University)
  • Lynn Laidlaw (University of Aberfeen)
  • Industry Participants
  • David Leventhal, MBA (Pfizer)
  • Richard Malamut, MD (Collegium)
  • Michael Cobas Meyer, MD, MBS (Eli Lilly)
  • Deborah Steiner, MD (Eli Lilly)